PL Stock Analysis: Planet Labs PBC | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 10.371m USD | 12M Return: 297.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 420M
Qual. Beats: 0
Rev. Trend: 96.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 5.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Planet Labs PBC (NYSE: PL) is a U.S.-based Earth observation and geospatial analytics company that designs, builds, and operates constellations of commercial satellites to deliver high-cadence imagery to customers globally. The company is headquartered in San Francisco, was founded in 2010, and operates as a Public Benefit Corporation (PBC), a legal structure that balances shareholder returns with a stated public or social mission.
Its satellite fleet includes the SuperDove constellation for daily global coverage at meter-level resolution, SkySat and Pelican satellites for high-resolution tasking imagery, and the Tanager hyperspectral satellite for full-spectrum data. Customers access the companys proprietary data catalog through its online Earth Observation platform, which provides APIs and browser-based tools for analysis and integration into GIS workflows.
Beyond selling imagery and data subscriptions, Planet Labs offers end-to-end satellite services, including custom satellite design and manufacturing, launch procurement, ground station operations, and dedicated tasking capacity, positioning it within the broader space-as-a-service and geospatial intelligence sector. Its customer base spans agriculture, mapping, energy, forestry, finance, and insurance companies, as well as government agencies. Planet Labs is classified under the Industrials sector, reflecting its hardware-and-data business model that combines satellite manufacturing with recurring software-driven data services.
- US government contract awards accelerate civil and defense revenue
- Data services margin expansion key to profitability path
- Pelican and Tanager satellite launches boost commercial imagery capacity
| Net Income: -373.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.29 > 0.02 and ΔFCF/TA -18.25 > 1.0 |
| NWC/Revenue: 162.8% < 20% (prev 68.06%; Δ 94.76% < -1%) |
| CFO/TA 0.11 > 3% & CFO 132.5m > Net Income -373.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (345.5m) vs 12m ago 15.07% < -2% |
| Gross Margin: 55.51% > 18% (prev 57.82%; Δ -2.31% > 0.5%) |
| Asset Turnover: 35.15% > 50% (prev 38.00%; Δ -2.85% > 0%) |
| Interest Coverage Ratio: -106.0 > 6 (EBIT TTM -364.3m / Interest Expense TTM 3.44m) |
| A: 0.44 (Total Current Assets 849.0m - Total Current Liabilities 302.5m) / Total Assets 1.25b |
| B: -1.27 (Retained Earnings -1.59b / Total Assets 1.25b) |
| C: -0.38 (EBIT TTM -364.3m / Avg Total Assets 954.9m) |
| D: 0.55 (Book Value of Equity 443.7m / Total Liabilities 807.7m) |
| Altman-Z'' = -3.26 = D |
| DSRI: 0.62 (Receivables 61.6m/74.7m, Revenue 335.6m/250.2m) |
| GMI: 1.04 (GM 57.82% / 55.51%) |
| AQI: 0.56 (AQ_t 0.16 / AQ_t-1 0.29) |
| SGI: 1.34 (Revenue 335.6m / 250.2m) |
| TATA: -0.40 (NI -373.1m - CFO 132.5m) / TA 1.25b) |
| Beneish M = -3.37 (Cap -4..+1) = AA |
As of July 10, 2026, the stock is trading at USD 27.20 with a total of 5,392,087 shares traded. Over the past week, the price has changed by -13.95%, over one month by -12.74%, over three months by -20.54% and over the past year by +297.08%.
Current recommended Stop Loss: 22.00 (which is 19.1% or 1.7 ATR below the current price).
Planet Labs PBC has received a consensus analysts rating of 4.45. Therefore, it is recommended to buy PL.
- StrongBuy: 7
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 39.8 | 46.3% |
P/S = 30.9027
P/B = 25.2058
Revenue TTM = 335.6m USD
EBIT TTM = -364.3m USD
EBITDA TTM = -322.4m USD
Long Term Debt = 447.6m USD (from longTermDebt, last quarter)
Short Term Debt = 3.39m USD (from shortTermDebt, last quarter)
Debt = 528.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 40.5m
Net Debt = -203.2m USD (calculated: Debt 528.5m - CCE 731.7m)
Enterprise Value = 10.2b USD (10.4b + Debt 528.5m - CCE 731.7m)
Interest Coverage Ratio = -106.0 (Ebit TTM -364.3m / Interest Expense TTM 3.44m)
EV/FCF = -28.44x (Enterprise Value 10.2b / FCF TTM -357.6m)
FCF Yield = -3.52% (FCF TTM -357.6m / Enterprise Value 10.2b)
FCF Margin = -106.5% (FCF TTM -357.6m / Revenue TTM 335.6m)
Net Margin = -111.2% (Net Income TTM -373.1m / Revenue TTM 335.6m)
Gross Margin = 55.51% ((Revenue TTM 335.6m - Cost of Revenue TTM 149.3m) / Revenue TTM)
Gross Margin QoQ = 53.53% (prev 54.17%)
Tobins Q-Ratio = 8.13 (Enterprise Value 10.2b / Total Assets 1.25b)
Interest Expense / Debt = 0.65% (Interest Expense 3.44m / Debt 528.5m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -287.8m (EBIT -364.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.72 (Total Current Assets 849.0m / Total Current Liabilities 311.6m)
Debt / Equity = 1.19 (Debt 528.5m / totalStockholderEquity, last quarter 443.7m)
Debt / EBITDA = 0.63 (negative EBITDA) (Net Debt -203.2m / EBITDA -322.4m)
Debt / FCF = 0.57 (negative FCF - burning cash) (Net Debt -203.2m / FCF TTM -357.6m)
Total Stockholder Equity = 354.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -39.07% (Net Income -373.1m / Total Assets 1.25b)
RoE = -105.3% (Net Income TTM -373.1m / Total Stockholder Equity 354.3m)
RoCE = -45.43% (EBIT -364.3m / Capital Employed (Equity 354.3m + L.T.Debt 447.6m))
RoIC = -30.76% (negative operating profit) (NOPAT -287.8m / Invested Capital 935.5m)
WACC = 15.55% (E(10.4b)/V(10.9b) * Re(16.32%) + D(528.5m)/V(10.9b) * Rd(0.65%) * (1-Tc(0.21)))
Discount Rate = 16.32% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 100.00 | Cagr: 8.68%
[DCF] Fair Price = unknown (Cash Flow -357.6m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.01 | # QB: 0
Revenue Correlation: 96.16 | Revenue CAGR: 16.71% | SUE: 0.81 | # QB: 0
EPS current Quarter (2026-07-31): EPS=-0.02 | Chg30d=N/A | Revisions=+62% | Analysts=7
EPS next Quarter (2026-10-31): EPS=-0.02 | Chg30d=N/A | Revisions=-25% | Analysts=7
EPS current Year (2027-01-31): EPS=-0.08 | Chg30d=+24.63% | Revisions=+62% | GrowthEPS=-103.6% | GrowthRev=+41.7%
EPS next Year (2028-01-31): EPS=0.00 | Chg30d=N/A | Revisions=+17% | GrowthEPS=+104.1% | GrowthRev=+30.9%
[Analyst] Revisions Ratio: +59% (up=12, down=2)